Clinical context

Cataract surgery outcomes are not defined by best-corrected visual acuity alone. Refractive accuracy, vision at different distances, spectacle dependence, contrast sensitivity, dysphotopsia and procedural safety all matter. Corneal and macular status, capsular support, cataract density and IOL calculation also shape the final result. A statistically convincing average therefore still has to be interpreted against the characteristics of an individual eye.

What was studied

A small Descemet detachment near the incision may escape microscopic detection, while a larger one can delay recovery. This study enrolled 179 consecutive eyes undergoing coaxial phacoemulsification through a 2.65-mm clear-corneal incision. Intraoperative OCT imaged the wound after each step. I/A incision-deformation time was cumulative instrument engagement with visible wound deformation. The protocol was registered as ChiCTR2100042379.

How the evidence was produced

A cohort study describes how outcomes are associated with an exposure or treatment in an observed clinical population. This design is useful for routine practice, uncommon events and longer follow-up, but it remains vulnerable to confounding by indication, baseline risk differences and missing data. An association should not automatically be interpreted as a causal effect.

Key result iOCT detected detachment in 109 of 179 eyes, 60.9%; irrigation-aspiration was the most frequent stage of first detection, accounting for 43.1%. Temporal analysis included 145 eyes without detachment at I/A onset: 75 developed a new event and 70 did not. Longer deformation time was independently associated with detachment, adjusted OR 1.23, 95% CI 1.12–1.36, and greater nucleus hardness had adjusted OR 4.20, 95% CI 2.08–8.50. Their AUCs were 0.728 and 0.726; the exploratory combined model had optimism-corrected AUC 0.800. All detachments resolved spontaneously by one month and BCVA did not differ.

How to interpret the result

The high rate reflects detection of small subclinical changes, not serious complications in 60.9%. The practical signal is to minimize prolonged I/A-tip deformation, especially with a dense nucleus. The data-derived 8.5-second cutoff is not universal without external validation. This association does not prove that changing technique reduces clinically important edema.

The result should be understood as an estimate for the population studied, not a promise of an individual outcome. Statistical and clinical significance, absolute and relative effects, and prespecified and exploratory analyses should be distinguished. When several endpoints or subgroups are reported, the prespecified primary endpoint for which the study was designed usually provides the most reliable inference.

Clinical applicability

This evidence is most useful as a basis for preoperative discussion and surgical planning. It helps identify which outcomes should be measured and which trade-offs should be explained to patients. The average effect should not be generalized to every IOL, technique or patient without checking eligibility criteria, surgeon experience, biometry, ocular comorbidity and duration of follow-up.

Limitations

This single-center study used one approach, limiting transfer to other wounds, instruments and surgeons. Eyes with corneal disease, low endothelial density and shallow chambers were excluded. Video-derived deformation time needs reproducibility testing. The model and cutoff were internally derived, and most detachments needed no treatment. Verify the OR time unit, masking, agreement, severity, follow-up, missing data, model and funding.

Beyond the limitations acknowledged by the authors, confidence is affected by sample size, follow-up duration, missing data, choice of comparator and relevance of the outcomes to routine care. Uncommon complications may remain undetected even in a well-conducted study. External validity is reduced when participants, equipment or investigator expertise differ substantially from everyday settings.

What to verify in the source

In the full paper, verify the protocol, eligibility criteria, baseline group characteristics, primary endpoint definition, confidence intervals, adverse events and losses to follow-up. Funding, conflicts of interest, trial registration and consistency between the published analysis and the original plan deserve separate attention. The DOI or source link below provides access to the primary publication for this check.